Background:
Taking the well-known drug, Piroxicam as a lead compound, we designed and synthesized two
series of 1,2-benzothiazines 1,1-dioxide derivatives to assay their ability in inhibition of HIV-1 replication in cell culture.
Objective:
In this study, we describe the synthesis, docking study and biological evaluation of 1,2-benzothiazines 1,1-
dioxide derivatives.
Results:
Most of the new compounds were active in the cell-based anti-HIV-1 assay with EC50 < 50 M. Among them,
compounds 7g was found to be the most active molecule. Docking study using 3OYA pdb code on the most active molecule
7g with EC50 values of 10 M showed a similar binding mode to the HIV integrase inhibitors.
Conclusion:
Since all the compounds showed no remarkable cytotoxicity (CC50> 500 M), the designed scaffold is
promising structure for development of new anti-HIV-1 agents.
Lead as a potent environmental and occupational pollutant, exerts its toxic effect mainly through oxidative stress induction. Currently, chelation therapy is the only medical management of metal intoxications in clinic, but its administration is associated with various side effects as well. In this study the protective effect of synthetized Piroxicam derivative was evaluated against lead toxicity in vitro. First the chelating activity of Piroxicam derivative was studied through Jobs method and 13C{1H} NMR spectroscopy. Then the cytoprotective effect of Piroxicam derivative (10, 20, 50, 100 and 200 μg/mL) was evaluated and compared with that of EDTA (30 μg/mL) in the presence of lead nitrate (30 μg/mL). The EC50 value of Piroxicam derivative was calculated as well. Finally, the chelation efficacy and antioxidant effects of Piroxicam derivative in EC50 and 2EC50 values was assessed and compared with that of EDTA. Results showed that Piroxicam derivative chelates lead ion as much as EDTA. Moreover, Piroxicam derivative prevented lead-induced cells death more effectively than EDTA which is may due to its potent innate antioxidant activity. In conclusion, the synthetized Piroxicam derivative with possessing potent chelating activity as well as potent antioxidant activity, could be considered as potential drug target in management of toxic metals poisoning.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.